[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.87.3. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 8, 1990

Pharmacoepidemiology

Author Affiliations

School of Graduate Biomedical Science Tufts University Boston, Mass

School of Graduate Biomedical Science Tufts University Boston, Mass

 

edited by Brian L. Strom, 424 pp, $71.95, ISBN 0-443-08675-3, New York, NY, Churchill Livingstone Inc, 1989.

JAMA. 1990;264(6):757-758. doi:10.1001/jama.1990.03450060103043

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

Pharmacoepidemiology is a growing discipline. Population studies of drug effects are of increasing importance to the pharmaceutical industry, the Food and Drug Administration, litigants, and the medical profession. Information about the adverse effects of drugs derives partly from controlled clinical trials performed prior to registration of a drug, but many effects of interest do not come to light until a drug is taken by large numbers of patients. Nailing down association between a drug and patient injury is difficult; proving causality is even harder.

Strom, one of the bright young American pharmacoepidemiologists, has convinced a number of the gurus in the field to write chapters for this book, which can easily serve as a primer for those wishing to get a start on their education in pharmacoepidemiology.

Almost half of the book is devoted to individual descriptions of various databases available for pharmacoepidemiologic studies, with attention to their advantages and

×